Proportionate Dwarfism in Mice Lacking Heterochromatin Protein 1 Binding Protein 3 (HP1BP3) Is Associated With Alterations in the Endocrine IGF-1 Pathway.
暂无分享,去创建一个
M. Bustin | C. Rosen | J. Orly | Y. Gabet | Benjamin P. Garfinkel | B. Garfinkel | P. Le | S. Arad | Yankel Gabet | Shiri Arad
[1] G. Werther,et al. IGFBP-2: The dark horse in metabolism and cancer. , 2015, Cytokine & growth factor reviews.
[2] M. Bustin,et al. HP1BP3 is a novel histone H1 related protein with essential roles in viability and growth , 2015, Nucleic acids research.
[3] G. Werther,et al. IGFBP-2 - taking the lead in growth, metabolism and cancer , 2015, Journal of Cell Communication and Signaling.
[4] G. Athanasiadis,et al. Heritability of Bone Mineral Density in a Multivariate Family-Based Study , 2014, Calcified Tissue International.
[5] R. Crystal,et al. Regulation of Insulin-like Growth Factor , 2013 .
[6] Tim D. Spector,et al. Genetics of osteoporosis from genome-wide association studies: advances and challenges , 2012, Nature Reviews Genetics.
[7] C. Long,et al. Genetic evidence that thyroid hormone is indispensable for prepubertal insulin‐like growth factor–I expression and bone acquisition in mice , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[8] S. Xuan,et al. Matrix IGF-1 maintains bone mass by activation of mTOR in mesenchymal stem cells , 2012 .
[9] D. Bailey,et al. Bone mineral accrual from 8 to 30 years of age: An estimation of peak bone mass , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[10] D. Larhammar,et al. Evolution of the insulin-like growth factor binding protein (IGFBP) family. , 2011, Endocrinology.
[11] Steven Boonen,et al. Skeletal sexual dimorphism: relative contribution of sex steroids, GH-IGF1, and mechanical loading. , 2010, The Journal of endocrinology.
[12] C. Farquharson,et al. The effect of GH and IGF1 on linear growth and skeletal development and their modulation by SOCS proteins. , 2010, The Journal of endocrinology.
[13] S. Yakar,et al. Elevated Serum Levels of IGF-1 Are Sufficient to Establish Normal Body Size and Skeletal Properties Even in the Absence of Tissue IGF-1 , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[14] K. Sjögren,et al. The role of liver-derived insulin-like growth factor-I. , 2009, Endocrine reviews.
[15] M. Bouxsein,et al. Serum IGF‐1 Determines Skeletal Strength by Regulating Subperiosteal Expansion and Trait Interactions , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[16] C. Rosen,et al. Insulin-like growth factor-I and bone: lessons from mice and men , 2009, Pediatric Nephrology.
[17] B. Clarke,et al. Normal bone anatomy and physiology. , 2008, Clinical journal of the American Society of Nephrology : CJASN.
[18] M. Bouxsein,et al. Gender-specific changes in bone turnover and skeletal architecture in igfbp-2-null mice. , 2008, Endocrinology.
[19] G. Mazziotti,et al. Growth hormone, insulin-like growth factors, and the skeleton. , 2008, Endocrine reviews.
[20] L. Melton,et al. High Serum IGFBP‐2 Is Predictive of Increased Bone Turnover in Aging Men and Women , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[21] S. Boonen,et al. Impact of Androgens, Growth Hormone, and IGF‐I on Bone and Muscle in Male Mice During Puberty , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[22] J. Holly,et al. The Role of Insulin-Like Growth Factor Binding Proteins , 2006, Neuroendocrinology.
[23] A. Berdal,et al. Insulin-like growth factor binding protein (IGFBP-1) involvement in intrauterine growth retardation: study on IGFBP-1 overexpressing transgenic mice. , 2006, Endocrinology.
[24] S. Ralston,et al. Genetic regulation of bone mass and susceptibility to osteoporosis. , 2006, Genes & development.
[25] A. Laib,et al. The use of micro-CT to evaluate cortical bone geometry and strength in nude rats: correlation with mechanical testing, pQCT and DXA. , 2006, Bone.
[26] Mary L Bouxsein,et al. Mechanisms of Disease: is osteoporosis the obesity of bone? , 2006, Nature Clinical Practice Rheumatology.
[27] S. Boonen,et al. Growth Without Growth Hormone Receptor: Estradiol Is a Major Growth Hormone‐Independent Regulator of Hepatic IGF‐I Synthesis , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[28] T. Niu,et al. The insulin-like growth factor-I gene and osteoporosis: a critical appraisal. , 2005, Gene.
[29] S. Mohan,et al. Impaired skeletal growth in mice with haploinsufficiency of IGF-I: genetic evidence that differences in IGF-I expression could contribute to peak bone mineral density differences. , 2005, The Journal of endocrinology.
[30] C. Slemenda,et al. The contribution of bone loss to postmenopausal osteoporosis , 1990, Osteoporosis International.
[31] S. Mohan,et al. The multi-functional role of insulin-like growth factor binding proteins in bone , 2005, Pediatric Nephrology.
[32] L. Melton,et al. A Potentially Deleterious Role of IGFBP‐2 on Bone Density in Aging Men and Women , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[33] T. Forrester,et al. The relationship among circulating insulin-like growth factor (IGF)-I, IGF-binding proteins-1 and -2, and birth anthropometry: a prospective study. , 2003, The Journal of clinical endocrinology and metabolism.
[34] R. Baxter,et al. Cellular actions of the insulin-like growth factor binding proteins. , 2002, Endocrine reviews.
[35] D. Leroith,et al. Circulating levels of IGF-1 directly regulate bone growth and density. , 2002, The Journal of clinical investigation.
[36] C. C. Pillai,et al. Altered placental development and intrauterine growth restriction in IGF binding protein-1 transgenic mice. , 2002, The Journal of clinical investigation.
[37] R. Wilkins,et al. Stat5b Is Required for Gh-induced Liver Igf-i Gene Expression Materials and Methods Animals , 2022 .
[38] J. Terwilliger,et al. Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth. , 2001, Developmental biology.
[39] R. Baron,et al. Bone homeostasis in growth hormone receptor-null mice is restored by IGF-I but independent of Stat5. , 2000, The Journal of clinical investigation.
[40] T. Wood,et al. Selective alterations in organ sizes in mice with a targeted disruption of the insulin-like growth factor binding protein-2 gene. , 2000, Molecular endocrinology.
[41] J. Gustafsson,et al. Estrogen receptor specificity in the regulation of skeletal growth and maturation in male mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[42] R. Marcus,et al. Peak Bone Mass , 2000, Osteoporosis International.
[43] A. Hoeflich,et al. Overexpression of Insulin-Like Growth Factor-Binding Protein-2 in Transgenic Mice Reduces Postnatal Body Weight Gain. , 1999, Endocrinology.
[44] J. Gustafsson,et al. Increased cortical bone mineral content but unchanged trabecular bone mineral density in female ERbeta(-/-) mice. , 1999, The Journal of clinical investigation.
[45] S. Mohan,et al. The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 1999 by The Endocrine Society Studies on the Potential Mediators of Skeletal Changes Occurring during Puberty in Girls* , 2022 .
[46] D. Leroith,et al. Normal growth and development in the absence of hepatic insulin-like growth factor I. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[47] A. Hoeflich,et al. Overexpression of insulin-like growth factor-binding protein-2 in transgenic mice reduces postnatal body weight gain. , 1999, Endocrinology.
[48] L. Donahue,et al. Insulin-Like Growth Factors and Bone: The Osteoporosis Connection Revisited , 1998, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[49] T. Wagner,et al. A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[50] S. Doublier,et al. Liver-Specific Expression of Human Insulin-Like Growth Factor Binding Protein-1 in Transgenic Mice: Repercussions on Reproduction, Ante- and Perinatal Mortality and Postnatal Growth. , 1997, Endocrinology.
[51] M. Savage,et al. Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. , 1996, The New England journal of medicine.
[52] S. Chua,et al. Nonsense mutation in the human growth hormone-releasing hormone receptor causes growth failure analogous to the little (lit) mouse , 1996, Nature Genetics.
[53] M. Lewitt,et al. Growth retardation and hyperglycemia in insulin-like growth factor binding protein-1 transgenic mice. , 1995, Endocrinology.
[54] J. Zerwekh,et al. Serum IGF 1 is low and correlated with osteoblastic surface in idiopathic osteoporosis , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[55] C. Roberts,et al. Expression of insulin-like growth factor binding proteins in the rat kidney: effects of long-term diabetes. , 1995, Endocrinology.
[56] J. Baker,et al. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r) , 1993, Cell.
[57] G. Saggese,et al. Effects of long-term treatment with growth hormone on bone and mineral metabolism in children with growth hormone deficiency. , 1993, The Journal of pediatrics.
[58] R R Recker,et al. Bone gain in young adult women. , 1992, JAMA.